mometasone 50micrograms/dose nasal spray
medihealth (northern) ltd - mometasone furoate - spray - 50microgram/1dose
mometasone 50micrograms/dose nasal spray
pilsco ltd - mometasone furoate - spray - 50microgram/1dose
nasonex 50 micrograms/actuation nasal spray, suspension
jv healthcare limited navi buidlings, pantar road, lija, lja 2021, malta - mometasone furoate - nasal spray, suspension - mometasone furoate 50 µg/spray - nasal preparations
elnaso 0.05% nasal spray
drogsan İlaçları sanayi ve ticaret a.Ş, turkey - mometasone furoate - nasal spray - 0.05 %
nasonex 50mcg/actuation nasal spray, suspension
neofarma pharmaceuticals limited 42-46, mill street, qormi, qrm 3105, malta - mometasone furoate - nasal spray, suspension - mometasone furoate 50 µg/spray - nasal preparations
nasonex spray nasal (suspension)
schering-plough labo n.v. - mometasone (mometasone furoate) - spray nasal (suspension) - 50mcg/dose
exnise nasal spray 0.05% wv
teva pharmaceutical investments singapore pte. ltd. - mometasone furoate monohydrate eqv mometasone furoate - spray, suspension - mometasone furoate monohydrate eqv mometasone furoate 0.05% w/v
mometasone spray, metered dose
sanis health inc - mometasone furoate (mometasone furoate monohydrate) - spray, metered dose - 50mcg - mometasone furoate (mometasone furoate monohydrate) 50mcg - corticosteroids
nasonex 50 micrograms/actuation nasal spray, suspension
n.v. organon kloosterstraat 6, nl-5349 ab oss, netherlands - mometasone furoate - nasal spray, suspension - mometasone furoate 50 µg - nasal preparations
enerzair breezhaler 114 mcg46 mcg136 mcg
novartis israel ltd - glycopyrronium as bromide; indacaterol as acetate; mometasone furoate - hard capsule - mometasone furoate 160 mcg; glycopyrronium as bromide 50 mcg; indacaterol as acetate 150 mcg - mometasone - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long-acting beta2-agonist and an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.important limitations of use:enerzair breezhaler is not indicated in patients with copd.